To assess the appropriateness of radiotherapy volume for patients receiving breast-conserving treatment (BCT) through analysis of recurrence pattern and factors affecting recurrence. Methods: From 1991 to 1996, 362 patients who received BCT were retrospectively evaluated. The radiation volume was the involved breast alone in the patients with less than 4 positive axillary lymph nodes (LNs), and breast and supraclavicular fossa in patients with 4 or more positive axillary LNs. The median follow-up period was 123 months (range, 3-169 months). Results: Ten-year overall, disease-free, local recurrence-free, and regional recurrence-free survival rates were 86.2%, 82.2%, 95.9%, and 95.2%, respectively. Among 310 patients receiving radiotherapy on the breast alone, 15 (4.8%) had regional recurrence. In particular, patients with inner quadrant lesions had high regional recurrence rates (11/98, 11.2%) (p <0.001). Conclusion: These low local recurrence rates may reveal that the current radiotherapy technique was successful. However, in cases of inner quadrant lesions, there were a considerable number of regional recurrences, even in N0 cases. This may suggest a potential role for irradiation on regional LNs in this group.
INTRODUCTION
Although breast conserving surgery (BCS) and irradiation is now considered as the preferable treatment method for patients with stage I and II breast cancer, some controversial issues regarding patient eligibility, radiotherapy volume, necessity of boost, and optimal combination of chemotherapy have not been solved yet. As for radiotherapy volume, the conventional approach is whole breast irradiation, typically followed by a boost to the primary tumor bed. It is controversial as to whether nodal areas should also be irradiated.
Since 1991, our institution has instituted a team approach for breast conservation treatment and we previously reported our radiation technique and short term follow-up result. (1, 2) As we started breast conserving treatment (BCT) after a National Institutes of Health (NIH) consensus conference(3) in 1990, we followed recommended radiotherapy techniques at that time and had consistently applied the treatment during that period to the patients reported in the current study.
As long-term follow-up is warranted for diseases with a long natural history such as breast cancer, we performed a retrospective analysis of long-term results for patients receiving BCT with early breast cancer. We analyzed the patterns of recurrence and the factors affecting recurrences. We also assessed the appropriateness of radiotherapy technique with a special interest in radiotherapy volume.
METHODS

Patient characteristics
Between 1991 and 1996, 362 patients with clinical stage I or II breast cancer were treated with conservative surgery and radiation therapy at Yonsei Cancer Center. Patients with synchronous or metachronous breast cancer were excluded. The median follow-up period was 123 months (range, 3-169 months 
Conservative surgery
All patients underwent lumpectomy or quadrantectomy.
Axillary LN dissection was performed in 361 (99.7%) patients. The median number of dissected LNs was 15 (range, . Thirteen (3.6%) cases had positive resection margins.
Radiation therapy
All patients were treated with radiotherapy using tangential fields directed at the whole breast after conservative surgery. Radiation was administered using 4-10 MV X-ray linear accelerators. Whole breast dose was 50.4 Gy (range, 45-55.8 Gy) with 1.8-2 Gy per fraction.
Tumor bed boost was performed with a 9-12 MeV electron beam. The median boost dose was 10 Gy (range, 10-20 Gy). In cases with positive or close resection margins, total radiation dose including boost dose was increased to 65 Gy. Irradiated volume was the involved breast alone with or without supraclavicular (SCL) fossa in most patients. Patients with 4 or more positive axillary LNs received SCL fossa irradiation. In cases of incomplete axillary LN dissection or extracapsular LN extension, we irradiated the axilla using posterior boost beam. Internal mammary nodes (IMNs) were not irradiated.
Chemotherapy
Systemic therapy was delivered at the discretion of the medical oncologist involved in each case. One hundred sixty-eight (46.4%) patients with positive axillary LNs or poor prognostic factors such as high nuclear or histological grades received chemotherapy. Cyclophosphamide,
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Statistical analysis
Overall and disease-free survivals were calculated using the Kaplan-Meier method, with the time period beginning at the time of surgery. Factors potentially affecting regional recurrence were evaluated in univariate analysis using log-rank test. Cox proportional hazards model was used for multivariate analysis.
RESULTS
Survival analysis
Ten-year overall, cause-specific, disease-free, local recurrence-free, regional recurrence-free, and distant recurrence-free survival rates were 86.2%, 87.3%, 82.2%, 95.9%, 95.2%, and 86.9%, respectively ( Figure 1 ). received systemic chemotherapy and radiotherapy at the site of regional recurrence.
Prognostic factors affecting overall and diseasefree survival
The results of univariate and multivariate analyses using log-rank test for overall and disease-free survival are shown in Table 3 . For overall survival, statistically significant differences were observed in pathological T, N, and AJCC stage in univariate analysis. In multivariate analysis, there were no statistically significant factors.
For disease-free survival, age; pathological T, N, and AJCC stage; and tumor location were statistically significant in univariate analysis. Patients with inner quadrant tumors showed worse disease-free survival than those with outer quadrant tumors (79.4% vs 86.4%). In multivariate analysis, age and pathological N stage were statistically significant.
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to radiation volume ( Table 4 ). Among N0 patients who received irradiation to the breast alone, 11 (4.7%) had regional recurrence. Four out of 76 (5.2%) N1 patients who received irradiation to the breast alone experienced regional recurrences. In patients who received SCL irradiation, only 2 showed regional recurrence, 1 of whom had upper neck nodal recurrence while the other had IMN recurrence. Both patients had accompanying distant metastasis and were deceased at 39 and 51 months, respectively. Univariate analyses of factors affecting regional recurrence in the breast alone radiation group were performed. Age and tumor location were found to be significant factors for regional recurrence. In multivariate analysis, only tumor location remained significant for regional recurrence. There were ten recurrences (10/81, 12.3%) in upper inner quadrant and one recurrence (1/17, 6%) in lower inner quadrant. When the tumor location was the inner quadrant, the incidence of regional recurrence was higher than the outer quadrant (11.2% vs 1.9%) ( Table 5 ). The site of regional recurrence in patients with inner quadrant tumor was in the SCL LN in 7 patients, in the IMN in 1 patients, in the neck node in 1 patient, and both in the SCL LN and IMN in 2 patients.
DISCUSSION
In this study, we report the long-term results of pati- We evaluated the properness of our radiotherapy technique by analyzing recurrence pattern. We observed a relationship between tumor location and regional recurrence. Regional recurrences were more common in the patients with tumors in the inner location than patients with tumors in the outer location. Ten-year overall survival rate and disease-free survival rate were also worse in the patients with inner location tumors. Most of patients with regional recurrences experienced subsequent distant metastases and in the end succumbed to the cancer. Ten out of seventeen (58.8%) developed distant metastasis and died within five years.
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axillary irradiation after complete axillary dissection. This was because, not only was the axillary node recurrence rate after axillary dissection negligibly low, but also axillary irradiation also added morbidities such as arm edema, breast edema, and brachial plexopathy. about risk factors for regional failure after BCT. Although the overall 10-yr regional nodal failure rate was less than 3%, axillary irradiation can significantly reduced the rate of axillary failure in patients with ≥4 positive nodes. The only significant predictor of regional nodal failure was the maximal size of the nodal metastasis. Therefore, a possible benefit to axillary irradiation in some subset of patients cannot be completely excluded.
The current standard of care for patients with negative axillary LNs remains to be whole breast irradiation.
Although accelerated partial breast irradiation has been developed and proven feasible with acceptable toxicity in some selective women, it has not yet been demonstrated in randomized trials. (16, 17) And SCL fossa irradiation is recommended for patients with more than three positive axillary LNs. However, the data supporting SCL node irradiation in patients with one to three positive axillary LNs is insufficient. (18) (19) (20) Therefore, we did not treat SCL fossa irradiation in patients with N0 or N1. And we did not consider IMN irradiation. Since our results showed that a considerable number of regional recurrences occurred in patients with medially located tumors, we began to recognize the necessity of IMN and SCL fossa irradiation. hormonal receptor status were predictive factors for regional recurrence. (7, 14, 24, 29) In this study, the regional recurrence rate in N0 patients who received breast alone irradiation was only 1.9% when the lesion was localized to the outer quadrant of the breast. However, the regional recurrence rate was 11.2% when the lesion was in the inner quadrant. This was statistically significant (p=0.006).
Although complete pathologic information was not available to determine the many factors responsible for patients such as hormonal receptor status, these findings support internal mammary node irradiation for medially located tumor. This issue should be evaluated in clinical trials which contain current chemotherapy and hormone therapy regimens.
CONCLUSION
According to our observations, we can conclude that our techniques of radiotherapy for BCT were relevant to positive clinical outcomes based on a low recurrence rate and comparable survival rate. However, in case of inner quadrant lesion, there were a considerable number of regional recurrences even in patients with negative axillary LNs. Based on the findings of this study, it could suggest a potential role for irradiation on regional nodes (IMN and SCL) for the treatment of patients with inner quadrant lesions.
